Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Telomir Pharmaceuticals , Inc. (NASDAQ:TELO), a $141 million market cap biopharmaceutical company engaged in age-reversal science, has announced significant preclinical study results today, indicating ...

Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2024 ...

Simon Nicholls, aged 55, is another person with Alzheimer’s who is featured in the CNN documentary and who took part in the ...

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps ...

Subtle signs of neurodegeneration can be detected in blood, CSF, and neuroimaging, up to 20 years before the motor symptoms ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...

Having ADHD is associated with a shorter life expectancy and a greater risk of mental health issues, according to a new study ...

“It can cause gastrointestinal issues if not needed,” warns Sharp.

Stanford Center for Biomedical Ethics (SCBE) has received a grant for expanding the Center for Ethical, Legal and Social Implications (ELSI) and Center for Resources and Analysis (CERA).

Their study showed that DCIS patients with pathogenic variants in BRCA1/2 and PALB2 had a higher risk of developing invasive breast cancer than those without.